Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis

2010/01/16 by Alison G. Cahill, Anthony Odibo, Anthony O. Odibo +5 · 27 citations
Medicine · Immunology and Microbiology · #Preterm Birth and Chorioamnionitis #Reproductive tract infections research #Maternal and Perinatal Health Interventions

paper · doi:10.1016/j.ajog.2009.12.005

Cited by

• SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth
• Can universal cervical length screening with vaginal progesterone for a short cervix reduce preterm birth? A systematic review and meta‐analyses
• Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last. [europepmc]
• Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix. [europepmc]
• Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. [europepmc]
• Is sonographic assessment of the cervix necessary and helpful? [europepmc]
• A proposed method to predict preterm birth using clinical data, standard maternal serum screening, and cholesterol. [europepmc]
• Impaired ultrasonographic cervical assessment after voiding: a randomized controlled trial. [europepmc]
• Activity restriction among women with a short cervix. [europepmc]
• Progesterone to prevent spontaneous preterm birth. [europepmc]
• Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review. [europepmc]
• Beyond Cervical Length: A Pilot Study of Ultrasonic Attenuation for Early Detection of Preterm Birth Risk. [europepmc]
• Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. [europepmc]
• Universal cervical length screening: implementation and outcomes. [europepmc]
• Predicting preterm birth: Cervical length and fetal fibronectin. [europepmc]
• Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. [europepmc]
• Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. [europepmc]
• First Trimester Circulating MicroRNA Biomarkers Predictive of Subsequent Preterm Delivery and Cervical Shortening. [europepmc]
• Current Approaches to Risk Assessment and Prevention of Preterm Birth-A Continuing Public Health Crisis. [europepmc]
• Cervical Assessment for Predicting Preterm Birth-Cervical Length and Beyond. [europepmc]
• Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm. [europepmc]
• Preterm Birth Prevention in Appalachian Kentucky: Understanding Barriers and Facilitators Related to Transvaginal Ultrasound Cervical Length Surveillance Among Prenatal Care Providers. [europepmc]
• Prevention of Preterm Birth with Progesterone. [europepmc]
• Vaginal Progesterone to Prevent Spontaneous Preterm Birth in Women With a Sonographic Short Cervix: The Story of the PREGNANT Trial. [europepmc]
• Neonatal Outcomes after Maternal Biomarker-Guided Preterm Birth Intervention: The AVERT PRETERM Trial. [europepmc]
• Multi-parametric quantitative evaluation of murine cervical remodeling during pregnancy and postpartum. [europepmc]
• Spectrum of Cervical Insufficiency: Management Strategies from Asymptomatic Shortening to Emergent Membrane Prolapse. [europepmc]